Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients
![PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/590fd910655ba40d90e40e5a20cdca99feb35b07/6-Table3-1.png "PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar")
PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar
Baseline patient characteristics by CNS-IPI score | Download Table
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Diffuse Large B-cell Lymphoma Prognosis Calculator
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Lymphoma IPI Score Calculator - Apps on Google Play
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu
Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma | Oncohema Key
Full article: Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study
Application of the Central Nervous System International Prognostic Index ( CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil - ScienceDirect
Jeremy Pantin (@JeremyPantinMD) / X
![PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/3-Table1-1.png "PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar")
PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL - ScienceDirect
Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review - ScienceDirect
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal
